Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | tert-Butanol | HCID 6386 | — |
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | HCID 18407013 | HCID 18407013 | — |
| Reactant | Potassium tert-butoxide | HCID 23665647 | — |
| Solvent | Methanol | HCID 887 | — |
| Solvent | Triethylamine | HCID 8471 | — |
| Solvent | Sodium Bicarbonate | HCID 516892 | — |
| Product | HCID 9798365 | HCID 9798365 | — |
Reaction Steps
A mixture of 0.32 g of 3-{2-[3-(4-benzyl-piperidin-1-yl)-butyl]-benzimidazol-1-yl}-propionitrile, 100 mL of tert-butanol and 1 g of potassium tert-butoxide was heated to reflux for 10 min. Conversion was complete by TLC (80:20:1 ethyl acetate:methanol:triethylamine). The mixture was cooled, diluted with 10 mL of saturated sodium bicarbonate and concentrated. The residue was partitioned between 3×100 mL of chloroform and 50 mL of water. After drying over magnesium sulfate and concentration under reduced pressure, the residue was purified by preparative TLC eluting with 90:10:2 chloroform:methanol:ammonium hydroxide. The major band (UV visualization) was 2-[3-(4-benzyl-piperidin-1-yl)-butyl]-1H-benzimidazole (250 mg): MS (m+1)=348.5; 1H NMR (400 MHz, CDCl3) 7.42 (s, 2H), 7.3 (m, 2H), 7.25 (m, 1H), 7.2 (m, 4H), 3.25 (m, 1H), 3.0 (m, 2H), 2.8 (d, 2H), 2.65 (m, 2H), 2.5 (m, 2H), 2.1 (m, 2H), 1.6 (d, 2H), 1.3 (m, 1H), 1.2 (d, 3H), 1.0 (m, 1H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06476041B1 |
|---|
| Source dataset | uspto-grants-2002_11 |
|---|
| ORD ID | ord-2c056ff089cc4ba483aad7a8b975b9b1 |
|---|
| Source note | uspto-grants-2002_11 |
|---|